NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/08/2026
Voltar para busca
Dado oficial do USPTO
TRX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
81
Atualização mais recente
04/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 40, 42
Data de depósito
11/04/2012
Data de registro
14/06/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/08/2026
Última transação
04/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Garforth, GB
Examinador
VANSTON, KATHY
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Tissue Regenix Limited
Tissue Regenix Limited
Representantes
Robert L. McRae GUNN, LEE & CAVE, P.C
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Living tissues for surgical implant; guided tissue regeneration materials comprised of biological decellularised material; implants comprising biological decellularised tissue for guided tissue regeneration; arteriovenous graftssurgical patches for vascular reconstructionreplacement heart valvessmall diameter graftsreplacement cartilage tissuesall made of living tissue; materials for dressingsgauze swabsbandagesself-adhesive bandages; all of aforesaid in the field of replacement tissues for humans and animals and replacement body parts for humans and animals ; and none relating to neurological diseases and disordersneurodegenerative diseases and disordersinfectious diseases and malaria
Classe 10
Implantable textile material to encourage the growth of tissue; replacement tissueartificial tissue being non-living surgical implants originally derived from humans and animalsintended for subsequent implantation comprising boneskinskin graftsuretersbladderstendonscartilageligamentsblood vesselsnervesdermal replacementstissue for use in treating chronic and acute woundstissue for use in treating burnssoft tissue used in the heart and pericardium; replacement prosthetic tissue for replacing animal tissue; replacement prosthetic tissue for replacing human tissue; implantable medical scaffolds comprising artificial materials for assisting regeneration of living tissue for living tissue; prosthetic arteriovenous graftsprosthetic replacement heart valvesprosthetic small diameter grafts; suture materials; all of aforesaid in the field of replacement tissues for humans and animals and replacement body parts for humans and animals ; and none relating to neurological diseases and disordersneurodegenerative diseases and disordersinfectious diseases and malaria
Classe 40
Treatment of living cells and tissueremoving immunogenic materials; all of aforesaid in the field of replacement tissues for humans and animals and replacement body parts for humans and animals; and none relating to neurological diseases and disordersneurodegenerative diseases and disordersinfectious diseases and malaria
Classe 42
Research and design services in the field of replacement tissues for humans and animalsregenerative medical devices; laboratory servicesresearch pertaining to material treatment for the production of living cellsproduction and decellularisation of tissuetreatment of replacement tissues for use in the human body and in animals; all of aforesaid in the field of replacement tissues for humans and animals and replacement body parts for humans and animals; and none relating to neurological diseases and disordersneurodegenerative diseases and disordersinfectious diseases and malaria
Publicações
Histórico de despachos e eventos da marca no USPTO.
81 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/08/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/08/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/08/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/06/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/06/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/06/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
04/06/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
14/06/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/03/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/03/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/03/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/03/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
17/05/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/05/2023
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
17/05/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/05/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/05/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
17/05/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
27/12/2022
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
27/12/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
21/12/2022
E815
TEAS SECTION 8 & 15 RECEIVED
08/06/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
14/06/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/06/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
14/06/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/03/2016
PUBO
PUBLISHED FOR OPPOSITION
29/03/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/03/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
19/02/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/01/2016
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
20/01/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
21/09/2015
GNSL
LETTER OF SUSPENSION E-MAILED
21/09/2015
CNSL
SUSPENSION LETTER WRITTEN
21/09/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/09/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/09/2015
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
14/09/2015
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
16/04/2015
GNSI
INQUIRY TO SUSPENSION E-MAILED
16/04/2015
CNSI
SUSPENSION INQUIRY WRITTEN
16/04/2015
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
15/04/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
15/10/2014
GNSL
LETTER OF SUSPENSION E-MAILED
15/10/2014
CNSL
SUSPENSION LETTER WRITTEN
15/10/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/10/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/10/2014
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/10/2014
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
29/09/2014
GNSI
INQUIRY TO SUSPENSION E-MAILED
29/09/2014
CNSI
SUSPENSION INQUIRY WRITTEN
29/09/2014
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
27/03/2014
GNSL
LETTER OF SUSPENSION E-MAILED
27/03/2014
CNSL
SUSPENSION LETTER WRITTEN
27/03/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/03/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/03/2014
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
26/03/2014
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
29/01/2014
GNSL
LETTER OF SUSPENSION E-MAILED
29/01/2014
CNSL
SUSPENSION LETTER WRITTEN
29/01/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/01/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/01/2014
ALIE
ASSIGNED TO LIE
26/01/2014
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
16/01/2014
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
13/08/2013
GNSI
INQUIRY TO SUSPENSION E-MAILED
13/08/2013
CNSI
SUSPENSION INQUIRY WRITTEN
13/08/2013
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
13/02/2013
GNSL
LETTER OF SUSPENSION E-MAILED
13/02/2013
CNSL
SUSPENSION LETTER WRITTEN
13/02/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/01/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/01/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/01/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/07/2012
GNRT
NON-FINAL ACTION E-MAILED
27/07/2012
CNRT
NON-FINAL ACTION WRITTEN
27/07/2012
DOCK
ASSIGNED TO EXAMINER
25/07/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/04/2012
NWAP
NEW APPLICATION ENTERED
14/04/2012
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TRX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.